Erjie Xia

1.2k total citations
52 papers, 789 citations indexed

About

Erjie Xia is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Erjie Xia has authored 52 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 18 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Erjie Xia's work include Thyroid Cancer Diagnosis and Treatment (15 papers), RNA modifications and cancer (14 papers) and Cancer-related molecular mechanisms research (12 papers). Erjie Xia is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (15 papers), RNA modifications and cancer (14 papers) and Cancer-related molecular mechanisms research (12 papers). Erjie Xia collaborates with scholars based in China, Nepal and United States. Erjie Xia's co-authors include Adheesh Bhandari, Ouchen Wang, Yanyan Shen, Fan Yang, Xiaofen Zhou, Xiaohua Zhang, Chen Zheng, Yizuo Chen, Yinghao Wang and Yinghao Wang and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Erjie Xia

51 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erjie Xia China 17 565 423 136 134 70 52 789
Adheesh Bhandari China 18 514 0.9× 375 0.9× 141 1.0× 138 1.0× 74 1.1× 66 819
Simeng Wen China 17 559 1.0× 407 1.0× 310 2.3× 224 1.7× 73 1.0× 30 933
Youngtae Jeong United States 11 504 0.9× 199 0.5× 154 1.1× 190 1.4× 93 1.3× 20 805
Kang‐Lai Wei China 13 441 0.8× 325 0.8× 148 1.1× 202 1.5× 64 0.9× 27 680
Dimitra Tsavachidou United States 10 395 0.7× 241 0.6× 203 1.5× 180 1.3× 74 1.1× 15 703
Libin Sun China 17 444 0.8× 334 0.8× 285 2.1× 165 1.2× 57 0.8× 45 847
Dong Hoon Shin South Korea 16 491 0.9× 311 0.7× 152 1.1× 271 2.0× 66 0.9× 40 830
Daniela Frezzetti Italy 13 358 0.6× 266 0.6× 110 0.8× 175 1.3× 59 0.8× 18 613
Dianyun Ren China 16 419 0.7× 202 0.5× 141 1.0× 261 1.9× 110 1.6× 25 708

Countries citing papers authored by Erjie Xia

Since Specialization
Citations

This map shows the geographic impact of Erjie Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erjie Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erjie Xia more than expected).

Fields of papers citing papers by Erjie Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erjie Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erjie Xia. The network helps show where Erjie Xia may publish in the future.

Co-authorship network of co-authors of Erjie Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Erjie Xia. A scholar is included among the top collaborators of Erjie Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erjie Xia. Erjie Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yuying, et al.. (2024). GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer. Breast Cancer Targets and Therapy. Volume 16. 71–89. 1 indexed citations
2.
Wu, Zhixuan, Xue Wu, Xiaowu Wang, et al.. (2024). Deep pan-cancer analysis and multi-omics evidence reveal that ALG3 inhibits CD8+ T cell infiltration by suppressing chemokine secretion and is associated with 5-fluorouracil sensitivity. Computers in Biology and Medicine. 177. 108666–108666. 5 indexed citations
3.
Hu, Chunlei, Hao Chen, Yinghao Wang, et al.. (2023). LINC00891 Promotes Tumorigenesis and Metastasis of ThyroidCancer by Regulating SMAD2/3 via EZH2. Current Medicinal Chemistry. 31(24). 3818–3833. 2 indexed citations
5.
Shen, Yanyan, et al.. (2023). The pan‐cancer analysis of the oncogenic role of FAM72A as a BRCA prognostic biomarker and immunotherapeutic target. Environmental Toxicology. 38(5). 1100–1117. 8 indexed citations
8.
Cai, Yaoyao, Erjie Xia, Kejian Shi, et al.. (2021). Apelin-13 Reverses Bupivacaine-Induced Cardiotoxicity via the Adenosine Monophosphate–Activated Protein Kinase Pathway. Anesthesia & Analgesia. 133(4). 1048–1059. 8 indexed citations
9.
Bhandari, Adheesh, et al.. (2021). PSD3 is an oncogene that promotes proliferation, migration, invasion, and G1/S transition while inhibits apoptotic in papillary thyroid cancer. Journal of Cancer. 12(18). 5413–5422. 8 indexed citations
10.
Zheng, Chen, et al.. (2020). Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial‐mesenchymal transition. Cell Biochemistry and Function. 38(2). 158–166. 5 indexed citations
12.
Wang, Yinghao, et al.. (2019). The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines. Human Cell. 32(3). 334–342. 26 indexed citations
13.
Bhandari, Adheesh, et al.. (2019). lncRNA FOXD3‐AS1 is associated with clinical progression and regulates cell migration and invasion in breast cancer. Cell Biochemistry and Function. 37(4). 239–244. 27 indexed citations
14.
Wang, Yinghao, et al.. (2019). IGSF1: A novel oncogene regulates the thyroid cancer progression. Cell Biochemistry and Function. 37(7). 516–524. 11 indexed citations
15.
Zheng, Chen, et al.. (2019). <p>NECTIN4 promotes papillary thyroid cancer cell proliferation, migration, and invasion and triggers EMT by activating AKT</p>. Cancer Management and Research. Volume 11. 2565–2578. 32 indexed citations
16.
Xiang, Jingjing, et al.. (2019). LINC00511 influences cellular proliferation through cyclin-dependent kinases in papillary thyroid carcinoma. Journal of Cancer. 11(2). 450–459. 11 indexed citations
17.
Zhou, Xiaofen, Erjie Xia, Adheesh Bhandari, et al.. (2018). LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer. Biochemical and Biophysical Research Communications. 503(1). 257–263. 16 indexed citations
18.
Xia, Erjie, Adheesh Bhandari, Yanyan Shen, et al.. (2018). LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma. Biochemical and Biophysical Research Communications. 496(2). 628–632. 27 indexed citations
19.
Bhandari, Adheesh, et al.. (2018). MAL2 promotes proliferation, migration, and invasion through regulating epithelial-mesenchymal transition in breast cancer cell lines. Biochemical and Biophysical Research Communications. 504(2). 434–439. 34 indexed citations
20.
Bhandari, Adheesh, et al.. (2017). Novel strategy of stents in thyroid mass: a case series report of managing severely dyspneic patients. OncoTargets and Therapy. Volume 10. 4997–5004. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026